Karen Sue Lynch Net Worth

The estimated Net Worth of Karen S Lynch is at least $45.5 Million dollars as of 3 May 2023. Ms Lynch owns over 14,000 units of CVS Health Corp stock worth over $24,205,405 and over the last 19 years she sold CVS stock worth over $17,456,791. In addition, she makes $3,836,578 as Pres and CEO & Director at CVS Health Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms Lynch CVS stock SEC Form 4 insiders trading

Ms has made over 19 trades of the CVS Health Corp stock since 2006, according to the Form 4 filled with the SEC. Most recently she bought 14,000 units of CVS stock worth $976,500 on 3 May 2023.

The largest trade she's ever made was selling 80,143 units of CVS Health Corp stock on 18 November 2019 worth over $6,010,725. On average, Ms trades about 4,956 units every 90 days since 2006. As of 3 May 2023 she still owns at least 431,392 units of CVS Health Corp stock.

You can see the complete history of Ms Lynch stock trades at the bottom of the page.

Ms. Karen Sue Lynch biography

Karen Sue Lynch is the Pres, CEO & Director at CVS Health Corp.

What is the salary of Ms Lynch?

As the Pres and CEO & Director of CVS Health Corp, the total compensation of Ms Lynch at CVS Health Corp is $3,836,578. There are 7 executives at CVS Health Corp getting paid more, with Larry Merlo having the highest compensation of $36,451,700.

How old is Ms Lynch?

Ms Lynch is 58, she's been the Pres and CEO & Director of CVS Health Corp since . There are 19 older and 9 younger executives at CVS Health Corp. The oldest executive at CVS Health Corp is Tony White, 73, who is the Independent Director.

What's Ms Lynch's mailing address?

Karen's mailing address filed with the SEC is CVS Drive, Woonsocket, Providence County, Rhode Island, 02895, United States.

Insiders trading at CVS Health Corp

Over the last 21 years, insiders at CVS Health Corp have traded over $183,836,314 worth of CVS Health Corp stock and bought 424,315 units worth $17,621,990 . The most active insiders traders include Michael F Mahoney, Thomas M Ryan, and Larry J Merlo. On average, CVS Health Corp executives and independent directors trade stock every 25 days with the average trade being worth of $4,897,842. The most recent stock trade was executed by Edward J Ludwig on 2 May 2024, trading 1,000 units of CVS stock currently worth $53,880.

What does CVS Health Corp do?

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.

Complete history of Ms Lynch stock trades at Magellan Health Inc, Cigna, CVS Health Corp, and U.S. Bancorp

CVS Health Corp executives and stock owners

CVS Health Corp executives and other stock owners filed with the SEC include:

• Larry Merlo,
  President, Chief Executive Officer, Director
• Thomas Moriarty,
  Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
• Jonathan Roberts,
  Chief Operating Officer, Executive Vice President
• Eva Boratto,
  Chief Financial Officer, Executive Vice President
• Troyen Brennan,
  Executive Vice President, Chief Medical Officer
• Eva C. Boratto,
  Exec. VP & CFO
• Jonathan C. Roberts,
  Exec. VP & COO
• Karen Sue Lynch,
  Pres, CEO & Director
• Dr. Alan M. Lotvin,
  Exec. VP & Pres of CVS Caremark
• David Dorman,
  Independent Chairman of the Board
• Edward Ludwig,
  Independent Director
• C. David Brown,
  Independent Director
• Nancy-Ann DeParle,
  Independent Director
• Anne Finucane,
  Independent Director
• Tony White,
  Independent Director
• Jean-Pierre Millon,
  Independent Director
• Alecia DeCoudreaux,
  Independent Director
• William Weldon,
  Independent Director
• Mary Schapiro,
  Independent Director
• Roger Farah,
  Independent Director
• Fernando Aguirre,
  Independent Director
• James Clark,
  Senior Vice President - Controller, Chief Accounting Officer
• Karen Lynch,
  Executive Vice President
• Alan Lotvin,
  Executive Vice President, President - CVS Caremark
• Joshua Flum,
  Executive Vice President - Enterprise Strategy and Digital
• Lisa Bisaccia,
  Chief Human Resource Officer, Executive Vice President
• Norman de Greve,
  Chief Marketing Officer & Director
• Thomas Michael Moriarty,
  Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel
• Susan V. Lisa,
  Sr. VP of Investor Relations
• James David Clark,
  Sr. VP, Controller & Chief Accounting Officer
• Shawn Michael Guertin,
  Exec. VP & CFO
• Katie Durant,
  Sr. Director of Investor Relations
• Eileen Howard Boone,
  Sr. VP & Chief Sustainability Officer
• Laurie P. Havanec,
  Exec. VP & Chief People Officer
• David A. Falkowski,
  Exec. VP & Chief Compliance Officer
• Valerie C. Haertel,
  Sr. VP of Investor Relations
• Neela Montgomery,
  EVP and Pres., Pharmacy/Retail
• J. David Joyner,
  EVP&President-PharmacyServices
• Andrew Sussman,
  SVP & President, MinuteClinic
• Richard M Bracken,
  Director
• Robert O. Kraft,
  EVP and President - Omnicare
• Richard J Swift,
  Director
• David M Denton,
  Controller
• Stephen J Gold,
  SVP & CIO
• Thomas F. Cowhey,
  EVP and CFO
• Jonathan E. Mayhew,
  EVP - Transformation
• Kevin Hourican,
  EVP & President, CVS Pharmacy
• Mark T Bertolini,
  Director
• Derica W Rice,
  EVP & President, CVS Caremark
• Helena Foulkes,
  Senior Vice President
• Kristen Gibney Williams,
  Director
• C A Piccolo,
  Director
• Mark Cosby,
  EVP & President-CVS/pharmacy
• Laird Daniels,
  SVP, Cont & Chief Acct Officer
• Howard A Mclure,
  President, Caremark Pharm Serv
• Chris W Bodine,
  Executive Vice President
• Paula A Price,
  Controller
• Edwin M Banks,
  Director
• David B Rickard,
  Chief Financial Officer
• V Michael Ferdinandi,
  Senior Vice President
• Roger L Headrick,
  Director
• William R Spalding,
  EVP Caremark Pharmacy Services
• Edwin M Crawford,
  Chairman
• Stuart M Mcguigan,
  SVP and CIO
• Thomas M Ryan,
  Chairman & CEO
• Terrence Murray,
  Director
• Marian L Heard,
  Director
• Sara Finley,
  SVP, Gen Counsel
• Douglas A Sgarro,
  Vice President
• Sheli Z Rosenberg,
  Director
• William H Joyce,
  Director
• W Don Cornwell,
  Director
• Gregory S Weishar,
  Vice President
• Alfred J Verrecchia,
  Director
• Larry D Solberg,
  Senior Vice President
• Stanley P Goldstein,
  Director
• Thomas P Gerrity,
  Director
• Terry R Lautenbach,
  Director
• Per Gh Lofberg,
  President, Caremark Pharm Serv
• Brian A Kane,
  EVP/President, Aetna
• Laurie P. Havanec,
  EVP and Chief People Officer
• J Scott Kirby,
  Director
• Daniel P Finke,
  EVP/Pres, Health Care Benefits
• Prem S Shah,
  EVP and Pres-Pharm, Consumer W
• Shawn M Guertin,
  EVP & Chief Financial Officer
• Michelle A Peluso,
  EVP and Co-President of Retail
• Sreekanth K Chaguturu,
  EVP and Chief Medical Officer
• Jeffrey R. Balser,
  Director
• Tilak Mandadi,
  EVP, Chief Technology Officer
• Samrat S. Khichi,
  EVP, CPO and General Counsel
• Michael F Mahoney,
  Director